DENOSUMAB, WITH AND WITHOUT BIOLOGIC THERAPY AND THE RISK OF INFECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：1
|
作者：
Haraoui, B. [1 ]
Choquette, D. [1 ]
Zoo, A. Adjo'o [1 ]
Coupal, L. [1 ]
机构：
[1] Inst Rhumatol Montreal, Rhumatol, Montreal, PQ, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.1465
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0137
引用
收藏
页码：243 / 244
页数：2
相关论文
共 50 条
  • [21] Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy A Meta-analysis
    Lopez-Olivo, Maria A.
    Tayar, Jean H.
    Martinez-Lopez, Juan A.
    Pollono, Eduardo N.
    Polo Cueto, Jose
    Rosa Gonzales-Crespo, M.
    Fulton, Stephanie
    Suarez-Almazor, Maria E.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (09): : 898 - 908
  • [22] DOES DENOSUMAB INCREASE INFECTION RATES IN RHEUMATOID ARTHRITIS PATIENTS ON BIOLOGICS?
    Toms, Tracey E.
    Afreedi, Shahzeb
    Salt, Karen
    Roskell, Samantha
    Passey, Kathleen
    Price, Thomas
    Venkatachalam, Srinivasan
    Sheeran, Thomas
    RHEUMATOLOGY, 2013, 52 : 117 - 117
  • [23] INFLUENCE OF BIOLOGIC AGENTS ON POSTOPERATIVE INFECTION IN RHEUMATOID ARTHRITIS PATIENTS
    Tada, M.
    Koike, T.
    Inui, K.
    Sugioka, Y.
    Mamoto, K.
    Okano, T.
    Nakamura, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 389 - 389
  • [24] The Risk of Solid Cancers in Patients with Rheumatoid Arthritis Exposed to Biologic Dmards with/without Prior Cancers
    Yamasaki, Masaomi
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [25] Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare
    Yun, Huifeng
    Xie, Fenglong
    Delzell, Elizabeth
    Levitan, Emily B.
    Chen, Lang
    Lewis, James D.
    Saag, Kenneth G.
    Beukelman, Timothy
    Winthrop, Kevin L.
    Baddley, John W.
    Curtis, Jeffrey R.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (01) : 56 - 66
  • [26] HEALTHCARE RESOURCE UTILIZATION AND INFECTION RISK IN RHEUMATOID ARTHRITIS PATIENTS WITH AND WITHOUT COMORBIDITIES
    Teeple, A.
    Ryan, M.
    Muirheid, L.
    Ellis, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 644 - 644
  • [27] Safety of biologic therapy in rheumatoid arthritis
    Woodrick, Robert S.
    Ruderman, Eric M.
    NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (11) : 639 - 652
  • [28] Use of Biologic Therapy As Monotherapy in Patients with Rheumatoid Arthritis.
    Gomez-Centeno, Antonio
    Martinez, Olga
    Javier Ballina, Francisco
    Manuel Rodriguez, Jose
    Grana, Jenaro
    Brito, Manuel
    Sampedro, Juana
    Iglesias, Gerardo
    Delgado, Concepcion
    Monteagudo, Indalecio
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1082 - S1083
  • [29] Safety of biologic therapy in rheumatoid arthritis
    Robert S. Woodrick
    Eric M. Ruderman
    Nature Reviews Rheumatology, 2011, 7 : 639 - 652
  • [30] Malignancy and biologic therapy in rheumatoid arthritis
    Askling, Johan
    Bongartz, Tim
    CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (03) : 334 - 339
12345